Preliminary Experience of Treating Children and Young Adults With Image-Guided Proton Beam Therapy in India.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Proton beam therapy (PBT) has been a preferred modality in pediatric malignancies requiring radiotherapy. We report our preliminary experience of treating consecutive patients younger than 25 years with image-guided pencil beam scanning PBT from the first and only center on the Indian subcontinent. Patients were selected for PBT on the basis of a multidisciplinary tumor board decision. Patient demographic data, as well as tumor and treatment-related characteristics of the cohort, were captured. Patient and treatment-related factors and their association with acute toxicities were analyzed using univariable and multivariable analyses. Forty-seven patients (27 with CNS and 20 with non-CNS tumors) with a median age of 9 years (range, 2-25 years) were evaluated. Most common diagnoses were ependymoma, rhabdomyosarcoma, and glioma. Seventy-seven percent of patients traveled more than 500 km, and 70% of them lived in metropolitan cities. Forty-nine percent of patients had recurrent disease at presentation, and 15% had received a previous course of radiation. The median dose delivered was 54.8 cobalt gray equivalents (range, 40.0-70.4 cobalt gray equivalents) to a median clinical target volume of 175 mL (range, 18.7-3,083.0 mL), with 34% of patients requiring concurrent chemotherapy (CCT). Acute grade 2 and grade 3 dermatitis, mucositis, and hematologic toxicity was noted in 45% and 2%, 34% and 0%, and 38% and 30% of patients, respectively. Grade 2 fatigue was noted in 26% of patients. On multivariable analysis, for CNS tumors, both CCT and craniospinal irradiation were independently associated with ≥ 2 grade hematologic toxicity, whereas among non-CNS tumors, a clinical target volume > 150 mL was associated with ≥ 2 grade fatigue, head and neck irradiation was associated with ≥ 2 grade mucositis, and CCT was associated with grade ≥ 2 hematologic toxicity. This study demonstrates safe implementation of a PBT program for children and young adults on the Indian subcontinent. Image-guided pencil beam scanning PBT in judiciously selected patients is feasible and can be delivered with acceptable acute toxicities.

Identifiants

pubmed: 33180633
doi: 10.1200/GO.20.00319
pmc: PMC7713582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1736-1745

Références

J Clin Oncol. 2014 Nov 20;32(33):3762-70
pubmed: 25332253
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):46-52
pubmed: 23778197
Lancet Oncol. 2016 Mar;17(3):287-298
pubmed: 26830377
Semin Radiat Oncol. 2012 Jan;22(1):50-61
pubmed: 22177878
Cancer. 2005 Feb 15;103(4):793-801
pubmed: 15637691
Cancer. 2015 May 15;121(10):1694-702
pubmed: 25641407
Cancer. 2016 May 15;122(10):1483-501
pubmed: 26828647
J Clin Oncol. 2020 Feb 10;38(5):454-461
pubmed: 31774710
J Clin Oncol. 2009 May 10;27(14):2339-55
pubmed: 19364955
Neurol India. 2020 Jan-Feb;68(1):189-191
pubmed: 32129277
Pract Radiat Oncol. 2014 Sep-Oct;4(5):336-341
pubmed: 25194103
J Oncol. 2019 Nov 27;2019:5879723
pubmed: 31885580
JAMA Oncol. 2017 Oct 1;3(10):1368-1376
pubmed: 28570730
Radiother Oncol. 2018 Jul;128(1):44-55
pubmed: 29937209
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):409-414
pubmed: 30763661
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1367-73
pubmed: 20934266
Radiother Oncol. 2010 Oct;97(1):119-26
pubmed: 20605649
Neuro Oncol. 2016 Jun;18(6):881-7
pubmed: 26688075
Radiat Oncol. 2020 Jun 1;15(1):138
pubmed: 32487113
Acta Oncol. 2014 Sep;53(9):1158-64
pubmed: 24913151
J Clin Oncol. 2014 Apr 20;32(12):1218-27
pubmed: 24638000
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):860-874
pubmed: 29976498
Ital J Pediatr. 2019 Dec 27;45(1):170
pubmed: 31881905
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):60-63
pubmed: 27816365
Acta Oncol. 2005;44(8):850-61
pubmed: 16332592
Pediatr Blood Cancer. 2013 Sep;60(9):1431-6
pubmed: 23610011
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Neurol India. 2020 Jan-Feb;68(1):42-44
pubmed: 32129241
Radiother Oncol. 2014 Oct;113(1):89-94
pubmed: 25304720
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):387-392
pubmed: 27598806
J Clin Oncol. 1999 Jul;17(7):2127-36
pubmed: 10561268
Front Oncol. 2018 May 24;8:165
pubmed: 29881715

Auteurs

Srinivas Chilukuri (S)

Apollo Proton Cancer Centre, Chennai, India.

Nagarjuna Burela (N)

Apollo Proton Cancer Centre, Chennai, India.

Ramya Uppuluri (R)

Apollo Proton Cancer Centre, Chennai, India.

D Indumathi (D)

Apollo Proton Cancer Centre, Chennai, India.

Sapna Nangia (S)

Apollo Proton Cancer Centre, Chennai, India.

Pankaj Kumar Panda (PK)

Apollo Proton Cancer Centre, Chennai, India.

Dayananda Sharma Shamurailatpam (DS)

Apollo Proton Cancer Centre, Chennai, India.

Revathi Raj (R)

Apollo Specialty Hospital, Chennai, India.

Thirumalai Raja (T)

Apollo Proton Cancer Centre, Chennai, India.

Rakesh Jalali (R)

Apollo Proton Cancer Centre, Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH